Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Wilson disease, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, inherited neurodegenerative disorder, liver disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease | Active, not recruiting | Not applicable | 2026-08-12 | NCT06663878 | |
| A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, urea cycle disorder | Recruiting | Not stated | 2026-04-27 | NCT06904027 | |
| Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Recruiting | Phase 2 | 2026-04-09 | NCT06314334 | |
| A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer | Locally Advanced Rectal Cancer (LARC) | Active, not recruiting | Not applicable | 2026-01-27 | NCT06688786 | |
| Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, neoplasm | Enrolling by invitation | Phase 2 | 2025-05-08 | NCT06963060 | |
| Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC | Biliary Tract Carcinoma | Not yet recruiting | Phase 2 | 2024-11-21 | NCT06699459 |